These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29710490)

  • 1. Anti-metastatic potential of a proton beam is regulated by p38 MAPK/c-Fos signaling pathway in TPA-treated HepG2 human hepatocellular carcinoma.
    Chun SY; Kim S; Nam KS; Lee KS
    Biomed Pharmacother; 2018 Mar; 99():904-912. PubMed ID: 29710490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive effects of a proton beam on tumor growth and lung metastasis through the inhibition of metastatic gene expression in 4T1 orthotopic breast cancer model.
    Kwon YS; Lee KS; Chun SY; Jang TJ; Nam KS
    Int J Oncol; 2016 Jul; 49(1):336-42. PubMed ID: 27176787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
    Wen-Sheng W
    Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells.
    Pan MH; Chiou YS; Chen WJ; Wang JM; Badmaev V; Ho CT
    Carcinogenesis; 2009 Jul; 30(7):1234-42. PubMed ID: 19447859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-invasion and anti-metastasis effects of Valjatrate E via reduction of matrix metalloproteinases expression and suppression of MAPK/ERK signaling pathway.
    Sun Y; Lan M; Chen X; Dai Y; Zhao X; Wang L; Zhao T; Li Y; Zhu J; Zhang X; Jiang H; Wu X; Chen C; Zhang T; Yan Z
    Biomed Pharmacother; 2018 Aug; 104():817-824. PubMed ID: 29703569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway.
    Zhu B; Shi S; Ma YG; Fan F; Yao ZZ
    Hepatogastroenterology; 2012 May; 59(115):785-9. PubMed ID: 22020916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells.
    Yeh MH; Kao ST; Hung CM; Liu CJ; Lee KH; Yeh CC
    Toxicol Lett; 2009 Feb; 184(3):204-10. PubMed ID: 19110045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzyl isothiocyanate inhibits metalloproteinase-2/-9 expression by suppressing the mitogen-activated protein kinase in SK-Hep1 human hepatoma cells.
    Hwang ES; Lee HJ
    Food Chem Toxicol; 2008 Jul; 46(7):2358-64. PubMed ID: 18502015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of matrix metalloproteinase 1 and urokinase-type plasminogen activator in the PKCα-p38 MAPK pathway-mediated progression of human liver cancer cells.
    Ye JC; Hsieh YS; Chen PN; Liu JY; Hsieh YH
    Drug Dev Res; 2023 Jun; 84(4):767-776. PubMed ID: 37005497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic potential in MDA-MB-231 human breast cancer cells is inhibited by proton beam irradiation via the Akt/nuclear factor-κB signaling pathway.
    Lee KS; Lee DH; Chun SY; Nam KS
    Mol Med Rep; 2014 Aug; 10(2):1007-12. PubMed ID: 24859472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hispolon suppresses SK-Hep1 human hepatoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen activator through the PI3K/Akt and ERK signaling pathways.
    Huang GJ; Yang CM; Chang YS; Amagaya S; Wang HC; Hou WC; Huang SS; Hu ML
    J Agric Food Chem; 2010 Sep; 58(17):9468-75. PubMed ID: 20698552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway.
    Liu WH; Chang LS
    J Cell Physiol; 2010 Sep; 224(3):775-85. PubMed ID: 20432471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
    Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
    Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
    Kim JR; Kim CH
    Int J Biochem Cell Biol; 2004 Nov; 36(11):2293-306. PubMed ID: 15313474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
    Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
    Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of TIMP-1 by genipin inhibits MMP-2 activities and suppresses the metastatic potential of human hepatocellular carcinoma.
    Wang N; Zhu M; Tsao SW; Man K; Zhang Z; Feng Y
    PLoS One; 2012; 7(9):e46318. PubMed ID: 23029478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
    Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
    Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frondoside A has an anti-invasive effect by inhibiting TPA-induced MMP-9 activation via NF-κB and AP-1 signaling in human breast cancer cells.
    Park SY; Kim YH; Kim Y; Lee SJ
    Int J Oncol; 2012 Sep; 41(3):933-40. PubMed ID: 22710811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.